Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

Thrombosis

Science in Thrombosis

Get a 360º view and stay up-to-date on Thrombosis with content selected for you

DVT in Post-partum Case of Caesarean Section

DVT in Post-partum Case of Caesarean Section

Learn More
VTE Incidence after Cesarean Delivery in Selected Guidelines

VTE Incidence after Cesarean Delivery in Selected Guidelines

Learn More
Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Learn More
Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Learn More
Recurrence of VTE in Patients with Recent Gestational DVT or PE

Recurrence of VTE in Patients with Recent Gestational DVT or PE

Learn More
Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade

Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade

Danish study finds more elderly and patients with comorbidities being diagnosed.

Learn More
Global use of RAM and Thromboprophylaxis in hospitalized patients

Global use of RAM and Thromboprophylaxis in hospitalized patients

Learn More
Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Learn More

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia
  • Cardiovascular

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Learn More
Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines
  • Cardiovascular

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Learn More
Evaluation of lipid management following ACS
  • Cardiovascular

Evaluation of lipid management following ACS

Learn More
Use of Lipid-Lowering Therapies Over 2 Years
  • Cardiovascular

Use of Lipid-Lowering Therapies Over 2 Years

Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease

Findings from Gould study

Learn More
The European experience: Swedeheart and AIFA registries
  • Cardiovascular

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Learn More
Perceptions and Barriers on the use of PCSK9 inhibitors
  • Cardiovascular

Perceptions and Barriers on the use of PCSK9 inhibitors

Learn More
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry
  • Cardiovascular

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

Learn More
PCSK9 inhibitors and ACS
  • Cardiovascular

PCSK9 inhibitors and ACS

Learn More

Events

Stay up to date and register for the latest events and view webinar recordings.

VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Learn More
Challenges of VTE Prophylaxis in Surgery

Challenges of VTE Prophylaxis in Surgery

Learn More
Venous Thromboembolism in Acutely Medically Ill Patients

Venous Thromboembolism in Acutely Medically Ill Patients

Learn More
Venous Thromboembolism Burden

Venous Thromboembolism Burden

Learn More
VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond

VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond

Prof. Joseph A. Caprini provides insights on VTE Risk in Hospital and beyond by supporting the initiative on  preventing the number one preventable cause of death after surgery: fetal pulmonary embolism

Learn More
VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

Learn More
VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Learn More
VTE Safety Zone: The Role of Thromboprophylaxis for the Prevention of VTE

VTE Safety Zone: The Role of Thromboprophylaxis for the Prevention of VTE

Learn More